Miles W. Griffis
-
Research updates, October 27
Low-dose prednisolone may temporarily reduce some “symptom severity” of Long COVID, according to a new study in eClinicalMedicine. German researchers evaluated the drug, a corticosteroid that reduces inflammation and is used to treat a broad range of conditions, alongside some B vitamins, in the phase 3 clinical trial.
-
Research updates, October 20
A large Long COVID review found mechanisms of “accelerated biological aging” in young adults. The review was published in Ageing Research Reviews and synthesized 110 mechanistic and epidemiological Long COVID studies on adults ages 25–55.
-
Research updates, October 13
A new study found COVID-19 was linked to a significant increase in dementia in older people with type 2 diabetes. The retrospective study published in Frontiers in Aging Neuroscience included a cohort of nearly half a million people with documented SARS-C0V-2 infections.
-
Research updates, October 6
As many as 2.3 million new cases of cancer were triggered by viral infections worldwide in 2024, according to new research in The Lancet Oncology. French researchers analyzed a large database of cancer incidence from 2024, looking at specific diagnoses that were attributable to infections.
-
Research updates, September 29
A small clinical trial found Remdesivir was safe for people with Long COVID and that some exploratory results warrant a larger trial. The U.K. trial, which included 73 participants who took a five day course of the intravenous antiviral COVID-19 drug, was published in Oxford Open Immunology.
-
Research updates, September 22
A small study in NeuroImage: Reports has found more evidence of reduced blood flow to the brain of people with Long COVID. The authors concluded that this abnormality was linked with fatigue, after they assessed brain imaging results of 22 people with Long COVID and compared them with 19 controls.
-
Research updates, September 15
Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions, according to a new study in the Canada Communicable Disease Report.
-
We made a COVID-19 memorial in the ashes of a Joshua tree forest
Despite nearly 1.3 million deaths and counting, there is still not a national memorial for the pandemic. Our informal memorial in the middle of the Mojave Desert is one small way to remember those we’ve lost so far.
-
Research updates, September 1
People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary (CRP) outcomes, according to a large observational study published in Journal of the American Heart Association. The study was a retrospective study and assessed more than 2.6 million people who developed COVID-19, comparing about 158,000 people who had been diagnosed with…
-
Research updates, August 25
Another observational study found more evidence of endothelial dysfunction in Long COVID. German researchers evaluated the eyes of 102 people with Long COVID, comparing them to 102 people “recovered” from COVID-19, as well as controls.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance